Bill Gates once quipped that there would be a PC on every desk and in every home running Microsoft software. Likewise, Lion Bioscience AG would like to see its software running on every computer in every life sciences laboratory. To accomplish this, the company plans to provide software solutions that address nearly every stage of drug development from discovery to clinical testing.

Last week, Lion (LEON; NMarkt:LIO, Heidelberg, Germany) filled in a missing piece, entering into a pilot